Antibody-drug conjugates (ADC), a fast-growing next-generation cancer treatment, have become an investment hotspot due to its potential to become mainstream…
Read More »Lung Cancer
Shares of Chinese drug firm Akeso – likened by some Western media outlets to artificial intelligence start-up DeepSeek – rose…
Read More »
Shares of Chinese cancer drug developer Akeso slumped on Monday despite the company receiving a second marketing approval from the…
Read More »
Research reveals that non-smokers with non-small cell lung cancer (NSCLC) often resist targeted treatments due to mutations in the EGFR…
Read More »